[PDF] Top 20 Original Article Peripheral circulating Ts (CD8+CD28-)/CD8+ is elevated in non small cell lung cancer patients
Has 10000 "Original Article Peripheral circulating Ts (CD8+CD28-)/CD8+ is elevated in non small cell lung cancer patients" found on our website. Below are the top 20 most common "Original Article Peripheral circulating Ts (CD8+CD28-)/CD8+ is elevated in non small cell lung cancer patients".
Original Article Peripheral circulating Ts (CD8+CD28-)/CD8+ is elevated in non small cell lung cancer patients
... Presently Ts or CD8+ Treg has been proved to play a role in various diseases including organ transplantation, autoimmune disease, inflam- matory disease and ...on CD8+ Treg’s role in tumor which are ... See full document
7
Original Article Circulating Bmi-1 mRNA as a diagnostic and prognostic biomarker for non-small cell lung cancer
... pancreatic cancer [29], cervical cancer [30], gastric carcinoma [31] and nasopharyngeal carcinoma ...noma patients [33], suggesting that Bmi-1 might play variable roles in the pathogenesis of ... See full document
8
Original Article Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy
... ml peripheral blood, and the blood was kept at -70ºC until ...from peripheral blood lymphocytes using the TIANamp Blood DNA Kit (Tiangen, Beijing, China) by the manufacturer’s ... See full document
7
Original Article Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer
... promote cell proliferation and angiogenesis ...in lung squamous carcinoma ...SCLC cell lines and animal model ...than non-smokers was consistent with the reports of it in NSCLC ...is ... See full document
9
Original Article Preoperative serum bilirubin levels associated with stage and prognosis in patients with stages I-III of non-small cell lung cancer in Jiangxi province, China
... 472 patients diagnosed with NSCLC (stage I-III), between March 2013 and July ...es; Elevated parameters in liver function tests (alanine aminotransferase >50 U/L; aspartate aminotransferase >40 U/L); ... See full document
10
Original Article Elevated expression of SHIP2 correlates with poor prognosis in non-small cell lung cancer
... Lung cancer (LC) is one of the most common and lethal human malignancies worldwide [1, ...China, lung cancer mortality has been increasing by more than 400% over the past three decades and is ... See full document
7
Original Article The diagnostic and prognostic role of circulating miR-141 expression in non-small-cell lung cancer patients
... both lung adenocar- cinoma patients (N=49) and lung SCC patients ...(N=52). Lung adenocarcinoma pati- ents with miR-141 low expres- sion displayed a longer OS compared with those with ... See full document
8
Original Article Detection of serum uroplakin 1A, cyclin D1 and MMP7 levels in patients with non-small cell lung cancer and their clinical significance
... ing lung cancer but not in normal epithelia, where it promotes proliferation, migration, and attenuation of apoptosis ...significantly elevated in cholangio- carcinoma patients (P < ... See full document
5
Original Article Elevated expression of DTYMK is associated with poor prognosis in patients with Non-small cell lung cancer
... with non-tumor ...colon cancer cells significantly decreased the dTTP pool, augmented the DNA damage response and enhanced apoptotic induction after exposure to low-dose doxorubicin, leading to cell ... See full document
7
Original Article The role of ATP8A1 in non-small cell lung cancer
... in non-small cell lung cancer (NSCLC) and to discover the role of ATP8A1 in the carcinogenesis of ...NSCLC patients in our hospital, among which 15 cases were found with lymph ... See full document
7
Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer
... of circulating tumor cells (CTCs) was de- scribed by Paget in 1889 ...in patients with primary lung cancer ...the peripheral blood of lung can- cer patients with no ... See full document
5
Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
... study. Patients were recruited as part of a project to improve the out- come of cancer chemotherapy, and so were referred to oncologists rather than ...in patients sero- positive for rheumatoid ... See full document
5
Original Article KDM4A, KDM4B and KDM4C in non-small cell lung cancer
... The patients were treated mainly with radical lobectomy or radical ...(3%) patients, respectively. The patients were followed-up by a senior physician accord- ing to a routine ... See full document
7
Prognostic value of angiopoietin 2 in non small cell lung cancer patients: a meta analysis
... Angiopoietin-1 (Ang-1) and Ang-2 are ligands for the tyrosine kinase receptor Tie2; they are not only widely expressed on many embryonic tissues, but also expressed on some cancer cells. There is a complicated and ... See full document
9
Original Article FRS2 promotes the progression of non-small cell lung cancer
... tion of cell lysates was deter- mined by BCA Protein Assay Kit (Beyotime, Beijing, China). 30 µg sample extract was resolved on 10% SDS-poly- acrylamide gels and tran- sferred onto polyvinylidene fluoride membrane ... See full document
8
Original Article Thyroid metastasis from non-small cell lung cancer
... Abstract: Non-thyroid malignancies to the thyroid gland resulting from distant metastases are extremely rare, and such cases are rarely seen in clinical ...of lung adenocarcinoma metastasizing to the ... See full document
9
Original Article Increased expression of TUSC3 in non-small cell lung cancer
... in non-small cell lung can- cer (NSCLC) compared to adjacent normal tissue, and its correlation with patients’ clinicopathological ...NSCLC patients were recruited, including 30 ... See full document
8
Original Article Diagnostic utility of PAX2 and PAX5 in distinguishing non-small cell lung cancer from small cell lung cancer
... B cell development, and is widely used in hema- topathology practice as a specific marker to recognize B cell ...the lung, especially SCLC and LCNEC [26], which is similar to the results of the ... See full document
8
<p>Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations</p>
... NSCLC patients with persistent response to chemother- apy since more than 50% of patients displayed disease progression during 6 – 8 cycles of ...of patients whose disease control is longer than 12 ... See full document
9
Original Article Long non-coding RNA HOST2 predicts poor prognosis and promotes cell proliferation and invasion in non-small cell lung cancer
... the cell metastasis ...the cancer progression was deteriorated ...the cell invasion and thereby enhances the capacity of movement and infection of the tumor cells ...tumor cell activities ... See full document
9
Related subjects